ACTRN12606000388516
Not yet recruiting
Phase 1
A trial to assess the safety of nebulised heparin for acute lung injury
St Vincents Health Melboune0 sites20 target enrollmentSeptember 5, 2006
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Acute lung injury
- Sponsor
- St Vincents Health Melboune
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Acute lung injurymechanical ventilation.
Exclusion Criteria
- •Systemic heparin administrationPulmonary haemorrhage.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 3
COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study)ACTRN12620000517976St Vincents Hospital Melbourne50
Completed
Phase 2
The comparison of the side effects of heparin and enoxaparin in patient with cesareacaesarean section.Delivery by elective caesarean sectionIRCT2016031427042N1Vice chancellor for research, Kerman University of Medical Sciences176
Not yet recruiting
Phase 2
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210513051275N1Islamic Azad University60
Completed
Not Applicable
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50
Completed
Phase 2
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500